Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine

Neuropharmacology
Diane I BitzingerYork A Zausig

Abstract

Previous and more recent studies show that cholinesterase inhibitors (ChE-Is) are an important possibility for therapeutic intervention in Alzheimer's Disease, sepsis and other inflammatory syndromes. ChE-Is maintain high levels of acetylcholine (ACh) determining beneficial effects on the disease process. Despite numerous efforts to identify the appropriate choice of agents and dose of ChE-Is, a common protocol regarding concentration- and species-dependent differences in inhibitory potency (IC 50) of clinical relevant ChE-Is is still not available. To evaluate the in vitro sensitivity of Acetyl- and Butyrylcholinesterase (AChE, BChE), we compared the concentration-response effects of physostigmine and neostigmine on cholinesterases in whole blood from rat and human. A spectrophotometrical test system based on in vitro Ellman's reagent has been used to determine the kinetic properties of clinical relevant ChE-Is. In vitro, the enzyme activity of human AChE and BChE was inhibited in a concentration-dependent manner until a residual activity of 4-6% for AChE and 20-30% for BChE (IC 50 human AChE: 0.117 ± 0.007 μM physostigmine, 0.062 ± 0.003 μM neostigmine; IC 50 human BChE: 0.373 ± 0.089 μM neostigmine; 0.059 ± 0.012 μM physosti...Continue Reading

References

Mar 1, 1975·Analytical Biochemistry·C D Johnson, R L Russell
Nov 1, 1989·Acta Anaesthesiologica Scandinavica·P HartvigL Wiklund
May 1, 1986·Clinical Pharmacokinetics·S M Aquilonius, P Hartvig
Aug 1, 1994·British Journal of Anaesthesia·N W Fleming, B K Lewis
Oct 26, 2001·Research in Veterinary Science·F Tecles, J J Cerón
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Dec 19, 2003·International Journal of Toxicology·Subramanya Karanth, Carey Pope
Mar 17, 2007·Scandinavian Cardiovascular Journal : SCJ·B TraboldD Fröhlich
Jun 5, 2007·Neuropharmacology·Philip G Jones, John Dunlop
Dec 20, 2007·Critical Care Medicine·Stefan HoferMarkus A Weigand
May 28, 2009·Journal of Separation Science·Yolanda Martín-BioscaMaria J Medina-Hernández
Jan 6, 2010·British Journal of Anaesthesia·A P WehrfritzW Koppert
Mar 6, 2012·The Annals of Pharmacotherapy·Jamie L ElsnerChristopher R Ensor
Jun 26, 2012·Immunological Reviews·Peder S OlofssonKevin J Tracey
Nov 22, 2012·Nature Reviews. Endocrinology·Valentin A Pavlov, Kevin J Tracey
Jan 15, 2013·Archives of Toxicology·Teresa R SternerJeffery M Gearhart
Mar 1, 2013·Developmental Neuroscience·Marco SifringerClaudia D Spies
Feb 1, 2014·Critical Care : the Official Journal of the Critical Care Forum·Klaus DistelmaierGeorg Goliasch

❮ Previous
Next ❯

Citations

Nov 20, 2018·Bulletin of Experimental Biology and Medicine·V N DubrovskiiA V Belkin
Apr 11, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haroon KhanSeema Patel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here